These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35349706)

  • 1. Oxidative stress-CBP axis modulates MOB1 acetylation and activates the Hippo signaling pathway.
    Jin J; Zhang L; Li X; Xu W; Yang S; Song J; Zhang W; Zhan J; Luo J; Zhang H
    Nucleic Acids Res; 2022 Apr; 50(7):3817-3834. PubMed ID: 35349706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LATS1 K751 acetylation blocks activation of Hippo signalling and switches LATS1 from a tumor suppressor to an oncoprotein.
    Yang S; Xu W; Liu C; Jin J; Li X; Jiang Y; Zhang L; Meng X; Zhan J; Zhang H
    Sci China Life Sci; 2022 Jan; 65(1):129-141. PubMed ID: 33945069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MOB1 Mediated Phospho-recognition in the Core Mammalian Hippo Pathway.
    Couzens AL; Xiong S; Knight JDR; Mao DY; Guettler S; Picaud S; Kurinov I; Filippakopoulos P; Sicheri F; Gingras AC
    Mol Cell Proteomics; 2017 Jun; 16(6):1098-1110. PubMed ID: 28373298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
    Mana-Capelli S; McCollum D
    J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kindlin-2 Inhibits the Hippo Signaling Pathway by Promoting Degradation of MOB1.
    Song J; Wang T; Chi X; Wei X; Xu S; Yu M; He H; Ma J; Li X; Du J; Sun X; Wang Y; Zhan J; Zhang H
    Cell Rep; 2019 Dec; 29(11):3664-3677.e5. PubMed ID: 31825843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable MOB1 interaction with Hippo/MST is not essential for development and tissue growth control.
    Kulaberoglu Y; Lin K; Holder M; Gai Z; Gomez M; Assefa Shifa B; Mavis M; Hoa L; Sharif AAD; Lujan C; Smith ESJ; Bjedov I; Tapon N; Wu G; Hergovich A
    Nat Commun; 2017 Sep; 8(1):695. PubMed ID: 28947795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.
    Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z
    J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer.
    Yang H; Hu J; Chen J; Chen Z; Jiao F; Cui J; Quan M; Wang L
    Med Oncol; 2020 Aug; 37(9):84. PubMed ID: 32780197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paris saponin VII, a Hippo pathway activator, induces autophagy and exhibits therapeutic potential against human breast cancer cells.
    Xiang YC; Peng P; Liu XW; Jin X; Shen J; Zhang T; Zhang L; Wan F; Ren YL; Yu QQ; Zhao HZ; Si Y; Liu Y
    Acta Pharmacol Sin; 2022 Jun; 43(6):1568-1580. PubMed ID: 34522004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Mps one binder kinase activator 1 (MOB1) expression with poor disease-free survival in individuals with non-small cell lung cancer.
    Ando N; Tanaka K; Otsubo K; Toyokawa G; Ikematsu Y; Ide M; Yoneshima Y; Iwama E; Inoue H; Ijichi K; Tagawa T; Nakanishi Y; Okamoto I
    Thorac Cancer; 2020 Oct; 11(10):2830-2839. PubMed ID: 32841529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator YAP.
    Thines L; Gorisse L; Li Z; Sayedyahossein S; Sacks DB
    J Biol Chem; 2022 May; 298(5):101839. PubMed ID: 35307353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ethyl acetate extract from Celastrus orbiculatus suppresses non-small-cell lung cancer by activating Hippo signaling and inhibiting YAP nuclear translocation.
    Jin F; Ni X; Yu S; Jiang X; Shi X; Zhou J; Mao D; Wang H; Liu Y; Wu F
    Phytomedicine; 2023 Jun; 114():154761. PubMed ID: 37028249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1.
    Ando T; Arang N; Wang Z; Costea DE; Feng X; Goto Y; Izumi H; Gilardi M; Ando K; Gutkind JS
    Commun Biol; 2021 Nov; 4(1):1237. PubMed ID: 34725466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Protein Interactions by
    Xiong S; Couzens AL; Kean MJ; Mao DY; Guettler S; Kurinov I; Gingras AC; Sicheri F
    Mol Cell Proteomics; 2017 Jun; 16(6):1111-1125. PubMed ID: 28373297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
    Chen M; Wang M; Xu S; Guo X; Jiang J
    Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.
    Lu J; Hu Z; Deng Y; Wu Q; Wu M; Song H
    J Biol Chem; 2021; 296():100400. PubMed ID: 33571521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of Yap, a Hippo signaling-related protein.
    Li C; Srivastava RK; Elmets CA; Afaq F; Athar M
    Biochem Biophys Res Commun; 2013 Sep; 438(4):607-12. PubMed ID: 23942117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
    Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
    Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer.
    Vahid S; Thaper D; Gibson KF; Bishop JL; Zoubeidi A
    Sci Rep; 2016 Aug; 6():31842. PubMed ID: 27555231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid-Liquid Phase Separation of DDR1 Counteracts the Hippo Pathway to Orchestrate Arterial Stiffening.
    Liu J; Wang J; Liu Y; Xie SA; Zhang J; Zhao C; Zhou Y; Pang W; Yao W; Peng Q; Wang X; Zhou J
    Circ Res; 2023 Jan; 132(1):87-105. PubMed ID: 36475898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.